Junye Wang

Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): A multi-center phase 3 trial

Zixian Wang, Chengxu Cui, Jun Yao et al. · Cancer Cell · 2022 · 565 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Clinical and biomarker analyses of sintilimab versus chemotherapy as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma: a randomized, open-label phase 2 study (ORIENT-2)

Jianming Xu, Yi Li, Qingxia Fan et al. · Nature Communications · 2022 · 150 citations · Full text

Medicine, Oncology, Pharmacology +17

Inhibition of NF-κB signaling unveils novel strategies to overcome drug resistance in cancers

Yuanfang Li, Baiwei Zhao, Juzheng Peng et al. · Drug Resistance Updates · 2024 · 101 citations · Full text

Medicine, Cancer Biology, Oncology +16

LINC00460 modulates KDM2A to promote cell proliferation and migration by targeting miR-342-3p in gastric cancer

Fang Wang, Shaobo Liang, Xiaowei Liu et al. · OncoTargets and Therapy · 2018 · 65 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Elevated levels of serum amyloid A indicate poor prognosis in patients with esophageal squamous cell carcinoma

Junye Wang, Yuzhen Zheng, Juan Yang et al. · BMC Cancer · 2012 · 63 citations · Full text

Medicine, Oncology, Pathology +17